Page 61 - Read Online

Yagawa et al. Cancer immunity and hyperthermia

Radiat Res 1986;105:307-19. 97. Boland CR, Goel A. Microsatellite instability in colorectal cancer.
79. Weichselbaum RR, Dahlberg W, Little JB. Inherently radioresistant Gastroenterology 2010;138:2073-87.
cells exist in some human tumors. Proc Natl Acad Sci U S A 98. Ribic CM, Sargent DJ, Moore MJ, Thibodeau SN, French AJ,
1985;82:4732-5. Goldberg RM, Hamilton SR, Laurent-Puig P, Gryfe R, Shepherd
80. Weichselbaum RR, Rotmensch J, Ahmed-Swan S, Beckett MA. LE, Tu D, Redston M, Gallinger S. Tumor microsatellite-instability
Radiobiological characterization of 53 human tumor cell lines. Int J status as a predictor of benefit from fluorouracil-based adjuvant
Radiat Biol 1989;56:553-60. chemotherapy for colon cancer. N Engl J Med 2003;349:247-57.
81. Vaupel P. Tumor microenvironmental physiology and its implications 99. Bonadonna G, Valagussa P. Dose-response effect of adjuvant
for radiation oncology. Semin Radiat Oncol 2004;14:198-206. chemotherapy in breast cancer. N Engl J Med 1981;304:10-5.
82. Masunaga S, Nagata K, Suzuki M, Kashino G, Kinashi Y, Ono K. 100. Shimizu K, Kotera Y, Aruga A, Takeshita N, Takasaki K,
Inhibition of repair of radiation-induced damage by mild temperature Yamamoto M. Clinical utilization of postoperative dendritic cell
hyperthermia, referring to the effect on quiescent cell populations. vaccine plus activated T-cell transfer in patients with intrahepatic
Radiat Med 2007;25:417-25. cholangiocarcinoma. J Hepatobiliary Pancreat Sci 2012;19:171-8.
83. Jorritsma JB, Kampinga HH, Scaf AH, Konings AW. Strand break 101. Sjoquist KM, Burmeister BH, Smithers BM, Zalcberg JR, Simes RJ,
repair, DNA polymerase activity and heat radiosensitization in Barbour A, Gebski V; Australasian Gastro-Intestinal Trials Group.
thermotolerant cells. Int J Hyperthermia 1985;1:131-45. Survival after neoadjuvant chemotherapy or chemoradiotherapy for
84. Devun F, Biau J, Huerre M, Croset A, Sun JS, Denys A, Dutreix resectable oesophageal carcinoma: an updated meta-analysis. Lancet
Oncol 2011;12:681-92.
M. Colorectal cancer metastasis: the DNA repair inhibitor Dbait 102. Du D, Liu Y, Qian H, Zhang B, Tang X, Zhang T, Liu W. The effects
increases sensitivity to hyperthermia and improves efficacy of of the CCR6/CCL20 biological axis on the invasion and metastasis of
radiofrequency ablation. Radiology 2014;270:736-46. hepatocellular carcinoma. Int J Mol Sci 2014;15:6441-52.
85. Ohguri T, Imada H, Korogi Y, Narisada H. Clinical results of systemic 103. Klevebro F, Johnsen G, Johnson E, Viste A, Myrnäs T, Szabo E,
chemotherapy combined with regional hyperthermia. Thermal Med Jacobsen AB, Friesland S, Tsai JA, Persson S, Lindblad M, Lundell
2007;23:49-61. L, Nilsson M. Morbidity and mortality after surgery for cancer of the
86. Hettinga JV, Konings AW, Kampinga HH. Reduction of cellular oesophagus and gastro-oesophageal junction: a randomized clinical
cisplatin resistance by hyperthermia--a review. Int J Hyperthermia trial of neoadjuvant chemotherapy vs. neoadjuvant chemoradiation.
1997;13:439-57. Eur J Surg Oncol 2015;41:920-6.
87. Da Silva VF, Feeley M, Raaphorst GP. Hyperthermic potentiation of 104. Stahl M, Walz MK, Stuschke M, Lehmann N, Meyer HJ, Riera-
BCNU toxicity in BCNU-resistant human glioma cells. J Neurooncol Knorrenschild J, Langer P, Engenhart-Cabillic R, Bitzer M,
1991;11:37-41. Königsrainer A, Budach W, Wilke H. Phase III comparison of
88. Correale P, Del Vecchio MT, La Placa M, Montagnani F, Di Genova preoperative chemotherapy compared with chemoradiotherapy in
G, Savellini GG, Terrosi C, Mannucci S, Giorgi G, Francini G, patients with locally advanced adenocarcinoma of the esophagogastric
Cusi MG. Chemotherapeutic drugs may be used to enhance the junction. J Clin Oncol 2009;27:851-6.
killing efficacy of human tumor antigen peptide-specific CTLs. J 105. Kitamura K, Kuwano H, Watanabe M, Nozoe T, Yasuda M,
Immunother 2008;31:132-47. Sumiyoshi K, Saku M, Sugimachi K. Prospective randomized study
89. Sugarbaker PH, Stuart OA, Vidal-Jove J, Pessagno AM, DeBruijn of hyperthermia combined with chemoradiotherapy for esophageal
EA. Pharmacokinetics of the peritoneal-plasma barrier after systemic carcinoma. J Surg Oncol 1995;60:55-8.
mitomycin C administration. Cancer Treat Res 1996;82:41-52. 106. Issels RD, Lindner LH, Verweij J, Wust P, Reichardt P, Schem BC,
90. Los G, van Vugt MJ, Pinedo HM. Response of peritoneal solid Abdel-Rahman S, Daugaard S, Salat C, Wendtner CM, Vujaskovic
tumours after intraperitoneal chemohyperthermia treatment with Z, Wessalowski R, Jauch KW, Dürr HR, Ploner F, Baur-Melnyk A,
cisplatin or carboplatin. Br J Cancer 1994;69:235-41. Mansmann U, Hiddemann W, Blay JY, Hohenberger P; European
91. Yonemura Y, Canbay E, Li Y, Coccolini F, Glehen O, Sugarbaker Organisation for Research and Treatment of Cancer Soft Tissue
PH, Morris D, Moran B, Gonzaletz-Moreno S, Deraco M, Piso P, and Bone Sarcoma Group (EORTC-STBSG); European Society for
Elias D, Batlett D, Ishibashi H, Mizumoto A, Verwaal V, Mahtem Hyperthermic Oncology (ESHO). Neo-adjuvant chemotherapy alone
H. A comprehensive treatment for peritoneal metastases from gastric or with regional hyperthermia for localised high-risk soft-tissue
cancer with curative intent. Eur J Surg Oncol 2016;42:1123-31. sarcoma: a randomised phase 3 multicentre study. Lancet Oncol
92. Fujishima Y, Goi T, Kimura Y, Hirono Y, Katayama K, Yamaguchi 2010;11:561-70.
A. MUC2 protein expression status is useful in assessing the 107. Kimura F, Shimizu H, Yoshidome H, Ohtsuka M, Miyazaki M.
effects of hyperthermic intraperitoneal chemotherapy for peritoneal Immunosuppression following surgical and traumatic injury. Surg
Today 2010;40:793-808.
dissemination of colon cancer. Int J Oncol 2012;40:960-4.
93. Cravioto-Villanueva A, Cavazos M, Luna-Perez P, Martinez-Gomez 108. Sacerdote P, Bianchi M, Gaspani L, Manfredi B, Maucione A, Terno
G, Ammatuna M, Panerai AE. The effects of tramadol and morphine
H, Ramirez ML, Solorzano J, Montiel H, Esquivel J. Cytoreductive on immune responses and pain after surgery in cancer patients. Anesth
surgery with hyperthermic intraperitoneal chemotherapy Analg 2000;90:1411-4.
(HIPEC) delivered via a modified perfusion system for peritoneal 109. Tsuchiya Y, Sawada S, Yoshioka I, Ohashi Y, Matsuo M, Harimaya
carcinomatosis of colorectal origin. Surg Today 2016;46:979-84. Y, Tsukada K, Saiki I. Increased surgical stress promotes tumor
94. Cummins KA, Russell GB, Votanopoulos KI, Shen P, Stewart JH, Levine metastasis. Surgery 2003;133:547-55.
EA. Peritoneal dissemination from high-grade appendiceal cancer treated 110. van der Zee J. Heating the patient: a promising approach? Ann Oncol
with cytoreductive surgery (CRS) and hyperthermic intraperitoneal 2002;13:1173-84.
chemotherapy (HIPEC). J Gastrointest Oncol 2016;7:3-9. 111. Feldmann HJ, Seegenschmiedt MH, Molls M. Hyperthermia--its
95. Sugarbaker PH. Peritoneal metastases from adrenal cortical carcinoma actual role in radiation oncology. Part III: Clinical rationale and
treated by cytoreductive surgery and hyperthermic intraperitoneal results in deep seated tumors. Strahlenther Onkol 1995;171:251-64.
chemotherapy. Tumori 2016;102:588-92. 112. Haveman J, Van Der Zee J, Wondergem J, Hoogeveen JF, Hulshof
96. Gnanamony M, Gondi CS. Chemoresistance in pancreatic cancer: MC. Effects of hyperthermia on the peripheral nervous system: a
Emerging concepts. Oncol Lett 2017;13:2507-13. review. Int J Hyperthermia 2004;20:371-91.
230 Journal of Cancer Metastasis and Treatment ¦ Volume 3 ¦ October 31, 2017